Psyence Biomedical sets Jan. 20 as effective date for reverse stock split
Source: SeekingAlpha
2026-01-15 01:46:22 ET
More on Psyence Biomedical Ltd.
- Seeking Alpha’s Quant Rating on Psyence Biomedical Ltd.
- Financial information for Psyence Biomedical Ltd.
Read the full article on Seeking Alpha
For further details see:
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split
Psyence Biomedical Ltd.
NASDAQ: PBM
PBM Trading
-1.5% G/L:
$2.54 Last:
4,073 Volume:
$2.50 Open:
PBM Latest News
March 11, 2026 09:15:00 am
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
March 03, 2026 09:15:00 am
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial
February 20, 2026 05:20:00 pm
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
February 17, 2026 09:15:00 am
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders
PBM Stock Data
$3,250,523
1,022,177
N/A
4
N/A
Biotechnology & Life Sciences
Healthcare
CA
Toronto
